Funabashi, Japan

Yudai Sugawara

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Nissan Chemical Corporation. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yudai Sugawara. Retrieved from https://idiyas.com/inventor/yudai-sugawara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 1.5

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yudai Sugawara: Innovator in Oligonucleotide Production

Introduction

Yudai Sugawara is a notable inventor based in Funabashi, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of oligonucleotides. His innovative approach has the potential to enhance the efficiency and stability of oligonucleotide production processes.

Latest Patents

Yudai Sugawara holds a patent for an oligonucleotide production method. This invention provides a novel technique for producing oligonucleotides using nucleosides or oligonucleotides that are easy to isolate and exhibit high storage stability. The method involves subjecting a nucleoside or oligonucleotide with a pseudo solid phase-protecting group to H-phosphonation, converting the hydroxyl group into an H-phosphonated form. This advancement is crucial for improving the production and application of oligonucleotides in various scientific fields.

Career Highlights

Sugawara is associated with Nissan Chemical Corporation, where he applies his expertise in biotechnology. His work at the company has allowed him to focus on innovative solutions that address challenges in oligonucleotide production. His contributions have been recognized within the industry, showcasing his commitment to advancing biotechnological methods.

Conclusion

Yudai Sugawara's work in oligonucleotide production exemplifies the impact of innovation in biotechnology. His patented method not only enhances production efficiency but also contributes to the stability of oligonucleotides, paving the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…